These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8047165)

  • 41. Vascular interactions of lipoprotein (a).
    Liu AC; Lawn RM
    Curr Opin Lipidol; 1994 Aug; 5(4):269-73. PubMed ID: 7981958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein(a) and atherogenesis.
    Liu AC; Lawn RM
    Trends Cardiovasc Med; 1994; 4(1):40-4. PubMed ID: 21244908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lipoprotein A].
    Verny C; Faucher C
    Ann Med Interne (Paris); 1992; 143(3):184-90. PubMed ID: 1524352
    [No Abstract]   [Full Text] [Related]  

  • 44. The Role of Lipoprotein(a) in Peripheral Artery Disease.
    Pavlatos N; Kalra DK
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.
    Lampsas S; Xenou M; Oikonomou E; Pantelidis P; Lysandrou A; Sarantos S; Goliopoulou A; Kalogeras K; Tsigkou V; Kalpis A; Paschou SA; Theofilis P; Vavuranakis M; Tousoulis D; Siasos G
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions.
    Al Hageh C; Chacar S; Ghassibe-Sabbagh M; Platt DE; Henschel A; Hamdan H; Gauguier D; El Murr Y; Alefishat E; Chammas E; O'Sullivan S; Abchee A; Nader M; Zalloua PA
    Vasc Health Risk Manag; 2023; 19():31-41. PubMed ID: 36703868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formation.
    Ruder S; Mansfield B; Immelman AR; Varki N; Miu P; Raal F; Tsimikas S
    Lipids Health Dis; 2022 Nov; 21(1):113. PubMed ID: 36320028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.
    Gu JX; Huang J; Li SS; Zhou LH; Yang M; Li Y; Zhang AM; Yin Y; Zhang N; Jia M; Su M
    Sci Rep; 2022 Mar; 12(1):3588. PubMed ID: 35246583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis.
    D'Ardes D; Santilli F; Guagnano MT; Bucci M; Cipollone F
    High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):1-8. PubMed ID: 31925708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated Lipoprotein(a) Levels Lower ABCA1 Cholesterol Efflux Capacity.
    Tavori H; Fenton AM; Plubell DL; Rosario S; Yerkes E; Gasik R; Miles J; Bergstrom P; Minnier J; Fazio S; Pamir N
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4793-4803. PubMed ID: 31220285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease.
    Tada H; Takamura M; Kawashiri MA
    J Atheroscler Thromb; 2019 Jul; 26(7):583-591. PubMed ID: 31061262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 4-
    Singha SK; Muhammad I; Ibrahim MA; Wang M; Ashpole NM; Shariat-Madar Z
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30699965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases.
    Shah P
    Curr Cardiol Rep; 2018 May; 20(7):51. PubMed ID: 29779055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.
    Teixeira V; Tam LS
    Front Med (Lausanne); 2017; 4():262. PubMed ID: 29435447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.
    Vassiliou VS; Flynn PD; Raphael CE; Newsome S; Khan T; Ali A; Halliday B; Studer Bruengger A; Malley T; Sharma P; Selvendran S; Aggarwal N; Sri A; Berry H; Donovan J; Lam W; Auger D; Cook SA; Pennell DJ; Prasad SK
    PLoS One; 2017; 12(7):e0181077. PubMed ID: 28704465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.
    Bandara EM; Ekanayake S; Wanigatunge CA; Kapuruge A
    BMC Cardiovasc Disord; 2016 Nov; 16(1):213. PubMed ID: 27825299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.
    Boffa MB
    Curr Atheroscler Rep; 2016 Dec; 18(12):69. PubMed ID: 27761705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse.
    An HJ; Lee WR; Kim KH; Kim JY; Kim WH; Park KK; Youn SW
    Int J Clin Exp Pathol; 2015; 8(4):3971-8. PubMed ID: 26097583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.
    Cha J; Niedzwiecki A; Rath M
    Am J Cardiovasc Dis; 2015; 5(1):53-62. PubMed ID: 26064792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
    Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
    Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.